[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-402501-105":59,"doc-detail-402501-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","prep-care-practice-aid-clinical-flow-chart","PrEP Care Practice Aid - Clinical Flow Chart","","This clinical practice aid provides a comprehensive flow chart for healthcare providers managing pre-exposure prophylaxis (PrEP) care. It details the essential steps for patient assessment, including HIV testing protocols, risk behavior evaluation, and prescribing guidelines. The document outlines current FDA-approved medication options, such as tenofovir alafenamide/emtricitabine and tenofovir disoproxil fumarate/emtricitabine. Additionally, it addresses patient accessibility, including insurance coverage, copayment assistance, and the schedule for ongoing follow-up appointments and monitoring to ensure long-term preventive efficacy.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":35,"@type":76,"position":81},"https://docshare.wps.com/document/healthcare/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/prep-care-practice-aid-clinical-flow-chart/402501/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/prep-care-practice-aid-clinical-flow-chart/402501.png","ImageObject",300,407,{"name":92,"@type":93},"Taylor Morgan","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-27",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"Which medications are currently approved by the FDA for PrEP?","Question",{"text":113,"@type":114},"The currently FDA-approved medications for PrEP are tenofovir alafenamide/emtricitabine and tenofovir disoproxil fumarate/emtricitabine.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"What is the recommended schedule for PrEP patient follow-up?",{"text":118,"@type":114},"Healthcare providers should schedule follow-up appointments every 3 months, which include HIV testing and prescription refills.",{"name":120,"@type":111,"acceptedAnswer":121},"What actions should a provider take if a patient is found to be HIV positive during the assessment?",{"text":122,"@type":114},"If the patient tests positive for HIV, the provider should either provide HIV treatment directly or refer the patient to appropriate services to maintain health and prevent further HIV transmission.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},402501,1790672422,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":34,"category_name":35,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":8,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":81,"preview_page_count":4},1099523885336,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Flow Chart: Any Prescribing Healthcare Provider Can Provide PrEP Care1-3  \nFull abbreviations, accreditation, and disclosure information available at  \n[PeerView.com/VQJ40](PeerView.com/VQJ40)  \n• If tests show reason not to prescribe PrEP (eg, abnormal kidney function), discuss other prevention methods  \n• If tests show patient still benefits from taking PrEP, go to next step  \n• Prescribe PrEP, and instruct patient to take one pill every day  \n• Currently tenofovir alafenamide/ emtricitabine or tenofovirdisoproxil fumarate/emtricitabine are only medications approved by the FDA for PrEP  \nPRESCRIBE  \n• If HIV positive, provide or refer patient for HIV treatment and other services to maintain health and prevent further spread of HIV  \n• If HIV negative, ask about sex and drug use behaviors  \n– If HIV risk is low, discuss prevention methods  \n– If HIV risk is high, discuss risk behaviors, PrEP, and use of other prevention methods  \n• Most public and private insurance programs cover PrEP, and patients can get help with their copayments  \n• Drug assistance programs can help patients without insurance pay for PrEP  \n• Schedule appointments every 3 months for follow-up, including HIV testing and prescription refills  \n1. [https://www.cdc.gov/vitalsigns/hivprep/index.html. 2. Truvada](https://www.cdc.gov/vitalsigns/hivprep/index.html. 2. Truvada) (emtricitabine and tenofovir disoproxil fumarate) Prescribing Information. [http://www.gilead.com/~/media/Files/pdfs/medicines/hiv/](http://www.gilead.com/~/media/Files/pdfs/medicines/hiv/)[ ](http://www.gilead.com/~/media/Files/pdfs/medicines/hiv/)truvada/truvada_pi.pdf. 3. Descovy (emtricitabine and tenofovir alafenamide) Prescribing Information. [https://www.gilead.com/~/media/Files/pdfs/medicines/hiv/descovy/descovy_pi.pdf.](https://www.gilead.com/~/media/Files/pdfs/medicines/hiv/descovy/descovy_pi.pdf.)","cbCaijtlcobw61Bz","https://ap.wps.com/l/cbCaijtlcobw61Bz","pdf",549934,"English","# Clinical Care Workflow for PrEP\n## Patient Assessment and Screening\n## Prescribing Guidelines\n## Patient Access and Follow-up","[{\"question\":\"Which medications are currently approved by the FDA for PrEP?\",\"answer\":\"The currently FDA-approved medications for PrEP are tenofovir alafenamide/emtricitabine and tenofovir disoproxil fumarate/emtricitabine.\"},{\"question\":\"What is the recommended schedule for PrEP patient follow-up?\",\"answer\":\"Healthcare providers should schedule follow-up appointments every 3 months, which include HIV testing and prescription refills.\"},{\"question\":\"What actions should a provider take if a patient is found to be HIV positive during the assessment?\",\"answer\":\"If the patient tests positive for HIV, the provider should either provide HIV treatment directly or refer the patient to appropriate services to maintain health and prevent further HIV transmission.\"}]","PrEP Care Practice Aid - Clinical Flow Chart | PDF",1790531147]